RDY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Dr Reddy's Laboratories Ltd (RDY) is not a good buy at the moment for a beginner investor with a long-term strategy. The technical indicators suggest a bearish trend, options data reflects low trading sentiment, and the company's financial performance has weakened significantly in the latest quarter. There are no positive catalysts or recent influential trades to justify an immediate investment.
The technical indicators are bearish. The MACD histogram is negative and contracting, RSI is neutral at 38.523, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 13.197, with resistance at 13.491 and support at 12.903.
NULL identified. No recent news or influential trades to act as a positive catalyst.
Weak financial performance in 2026/Q3 with YoY declines in revenue (-1.02%), net income (-18.84%), EPS (-20%), and gross margin (-8.61%). Technical indicators and options data reflect bearish sentiment.
In 2026/Q3, revenue dropped by -1.02% YoY to 979.8M, net income dropped by -18.84% YoY to 135.8M, EPS dropped by -20% YoY to 0.16, and gross margin dropped by -8.61% YoY to 53.63.
No recent analyst rating or price target changes available.
